GlaxoSmithKlineThe Impact of Medicines - Annual Review 2002
Reporting Front PageDownloads

Annual Review 2002 home
Chairman and Chief Executive Officer's statement
Patients and product development
R&D productivity
Innovative science
Diseases of the developing world
Our people
Corporate and social responsibility
Product portfolio
The Board
The Corporate Executive Team
Business operating review
Responsibility statement
Corporate governance
Summary financial statement
Summary remuneration report
Shareholder information
Contact details
The Board
 
Previous
Next

The Board of Directors is ultimately accountable for the Group's activities, strategy and financial performance.

Sir Christopher Hogg SIR CHRISTOPHER HOGG (BDFH), Non-Executive Chairman (Aged 66): Sir Christopher was formerly a Non-Executive Director of SmithKline Beecham plc. He is Non-Executive Chairman of Reuters Group PLC, and a member of the Supervisory Board of Air Liquide S.A. and Chairman of The Royal National Theatre.
Sir Roger Hurn SIR ROGER HURN (DHJ), Non-Executive Deputy Chairman (Aged 64): Sir Roger was appointed a Non-Executive Director of Glaxo Wellcome plc in 1996 and Deputy Chairman in 1997. He is a Non-Executive Director of Cazenove Group plc. He is also Chairman of the Court of Governors of Henley College.
Dr Jean-Pierre Garnier DR JEAN-PIERRE GARNIER (D), Chief Executive Officer (Aged 55): Dr Garnier was appointed an Executive Director of SmithKline Beecham plc in 1992, and became Chief Executive Officer in April 2000. He is a Non-Executive Director of United Technologies Corporation and a member of the Board of Trustees of the Eisenhower Exchange Fellowships. He holds a PhD in pharmacology from the University of Louis Pasteur in France and an MBA from Stanford University in the USA.
John Coombe JOHN COOMBE (D), Chief Financial Officer (Aged 57): Mr Coombe was formerly an Executive Director of Glaxo Wellcome plc where he was responsible for Finance and Investor Relations. He is a member of the Supervisory Board of Siemens AG, the UK Accounting Standards Board and the Code Committee of the UK Takeover Panel.
Paul Allair PAUL ALLAIRE (DI), Non-Executive Director (Aged 64): Mr Allaire was formerly a Non-Executive Director of SmithKline Beecham plc. He is a Non-Executive Director of Lucent Technologies Inc. and priceline.com Inc. He is Chairman of The Ford Foundation.
Dr Michele BarzachDR MICHÈLE BARZACH (DFJ), Non-Executive Director (Aged 59): Dr Barzach was formerly a Non-Executive Director of Glaxo Wellcome plc. She is a member of the International Cooperation High Council, Chairman of the Board of Equilibres et Populations and Director of the Board of Project Hope. International consultant on health strategy, she was formerly French Minister of Health and the Family.
Sir Peter Job SIR PETER JOB (BDJ), Non-Executive Director (Aged 61): Sir Peter was formerly a Non-Executive Director of Glaxo Wellcome plc. He is a Non-Executive Director of Schroders plc, Shell Transport and Trading Company plc, TIBCO Software Inc, Instinet Group Inc. and Multex.com Inc. He is also a member of the Supervisory Boards of Deutsche Bank AG and Bertelsmann AG.
John McArthur JOHN MCARTHUR (DHJ), Non-Executive Director (Aged 68): Mr McArthur was formerly a Non-Executive Director of Glaxo Wellcome plc. He is a Non-Executive Director of BCE Inc., BCE Emergis Inc., Cabot Corporation, HCA Corporation Koc Holdings A.S., Rohm and Haas Company, Telsat Canada and The AES Corporation. He is also Senior Advisor to the President of the World Bank.
Donald McHenry DONALD MCHENRY (DEH), Non-Executive Director (Aged 66): Mr McHenry was formerly a Non-Executive Director of SmithKline Beecham plc. He is a Distinguished Professor in the Practice of Diplomacy at the School of Foreign Service at Georgetown University and President of the IRC Group, LLC. His other Non-Executive directorships include The Coca-Cola Company, FleetBoston Financial Corporation,International Paper Company and AT&T Corporation. He previously served as Ambassador and US Permanent Representative to the United Nations.
Sir Ian Prosser SIR IAN PROSSER (BDG), Non-Executive Director (Aged 59): Sir Ian was formerly a Non-Executive Director of SmithKline Beecham plc. He is Executive Chairman of Six Continents PLC and the World Travel and Tourism Council and Non-Executive Deputy Chairman of BP plc. He is a member of the CBI President's Committee.
Dr Ronaldo Schmitz DR RONALDO SCHMITZ (AD), Non-Executive Director (Aged 64): Dr Schmitz was formerly a Non-Executive Director of Glaxo Wellcome plc. He is a Non-Executive Director of Legal and General Group plc and a member of the Board of Directors of Rohm and Haas Company and Cabot Corporation. Non-Executive Director (Aged 64)Dr Schmitz was formerly a Non-Executive Director of Glaxo Wellcome plc. He is a Non-Executive Director of Legal and General Group plc and a member of the Board of Directors of Rohm and Haas Company and Cabot Corporation.
Dr Lucy ShapiroDR LUCY SHAPIRO (DF), Non-Executive Director (Aged 62): Dr Shapiro was formerly a Non-Executive Director of SmithKline Beecham plc. She is Ludwig Professor of Cancer Research in the Department of Developmental Biology and Director of the Beckman Centre for Molecular and Genetic Medicine at the Stanford University School of Medicine. She holds a PhD in molecular biology from the Albert Einstein College of Medicine.
Other Directors: Sir Richard Sykes - Non-Executive Chairman, Sir Peter Walters - Non-Executive Deputy Chairman and Mr John Young - Non-Executive Director, all retired from the Board on 20th May 2002.
Key: Membership of Board committees symbols
 
Previous
Next


Top


Annual Review 2002 Home | Reporting Front Page | Downloads | Main Site
 
Updated March 28, 2003 - © 2005 GlaxoSmithKline - All Rights Reserved
Legal Notices - Privacy Statement